HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A small molecule SMAC mimic LBW242 potentiates TRAIL- and anticancer drug-mediated cell death of ovarian cancer cells.

AbstractBACKGROUND:
Ovarian cancer remains a leading cause of death in women and development of new therapies is essential. Second mitochondria derived activator of caspase (SMAC) has been described to sensitize for apoptosis. We have explored the pro-apoptotic activity of LBW242, a mimic of SMAC/DIABLO, on ovarian cancer cell lines (A2780 cells and its chemoresistant derivative A2780/ADR, SKOV3 and HEY cells) and in primary ovarian cancer cells. The effects of LBW242 on ovarian cancer cell lines and primary ovarian cancer cells was determined by cell proliferation, apoptosis and biochemical assays.
PRINCIPAL FINDINGS:
LBW242 added alone elicited only a moderate pro-apoptotic effect; however, it strongly synergizes with tumor necrosis factor-related apoptosis inducing ligand (TRAIL) or anticancer drugs in inducing apoptosis of both ovarian cancer cell lines and primary ovarian cancer cells. Mechanistic studies show that LBW242-induced apoptosis in ovarian cancer cells is associated with activation of caspase-8. In line with this mechanism, c-FLIP overexpression inhibits LBW242-mediated apoptosis.
CONCLUSION:
LBW242 sensitizes ovarian cancer cells to the antitumor effects of TRAIL and anticancer drugs commonly used in clinic. These observations suggest that the SMAC/DIABLO mimic LBW242 could be of value for the development of experimental strategies for treatment of ovarian cancer.
AuthorsEleonora Petrucci, Luca Pasquini, Manuela Bernabei, Ernestina Saulle, Mauro Biffoni, Fabio Accarpio, Simone Sibio, Angelo Di Giorgio, Violante Di Donato, Assunta Casorelli, Pierluigi Benedetti-Panici, Ugo Testa
JournalPloS one (PLoS One) Vol. 7 Issue 4 Pg. e35073 ( 2012) ISSN: 1932-6203 [Electronic] United States
PMID22558117 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Annexin A5
  • Antineoplastic Agents
  • LBW242
  • Oligopeptides
  • TNF-Related Apoptosis-Inducing Ligand
  • Topotecan
Topics
  • Analysis of Variance
  • Annexin A5
  • Antineoplastic Agents (metabolism)
  • Blotting, Western
  • Cell Death (drug effects)
  • Cell Line, Tumor
  • Drug Synergism
  • Female
  • Flow Cytometry
  • Humans
  • In Vitro Techniques
  • Oligopeptides (metabolism, pharmacology)
  • Ovarian Neoplasms (drug therapy, metabolism)
  • TNF-Related Apoptosis-Inducing Ligand (metabolism)
  • Topotecan (metabolism)
  • Transduction, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: